Between the notice and the split, Ohmyhome priced a registered direct offering of about USD 4 million on July 27, 2026, selling 20,000,000 Class A ordinary shares, or pre-funded warrants, at USD 0.20 per share, and the offering closed on July 28. Simple arithmetic …
Cash used inOperating Activitieswidened to USD 3.19 million from USD 390,299, so theBusinessitself consumed money. Financing brought in USD 13.94 million, including USD 12.95 million from sales of ordinary shares, net of issuance costs. Shares outstanding stood at 2,322,391 at June 30, 2026, against …
Growth came at a cost. Selling, general and administrative expenses climbed to USD 99.6 million from USD 62.4 million, which is roughly a 60% rise by simple arithmetic on two published numbers, whileResearch and Developmentwas USD 22.4 million against USD 19.6 million. Cash, restricted …
The step follows a Nasdaq deficiency letter dated May 6, 2026. Nasdaq said the closing bid price of the ADSs had been below the USD 1.00 minimum required by Listing Rule 5550(a)(2) for 30 consecutive business days, from March 24, 2026 through May 5, …
The most recent financial summary found is published coverage dated August 13, 2026 for the first half of 2026, which is single-source and should be treated as approximate. It described TAO holdings atFair Valueof USD 16.8 million, about 88% of treasury assets, staking revenue …
The company completed a direct listing onNasdaqon May 20, 2026 under the symbol AMSS, which means shares began trading without a conventional underwritten offering. Its portfolio spans wine, spirits and non-alcoholic products. Using NielsenIQ data for the latest four weeks, Good Twin retail dollar …
Chairman and Chief Executive Zvi Alon said revenue was within guidance and that adjusted EBITDA exceeded the high end of the range. Operating expenses were USD 11.2 million, down 10.0%. For nine months, revenue was USD 74.6 million against USD 73.5 million, and GAAP …
Chief Executive Anthony Carroll said the company delivered a strong quarter with revenue up 25% sequentially and margins ahead of its targets. Fourth-quarter guidance is revenue of USD 44 million to USD 52 million, non-GAAP gross profit of USD 5.0 million to USD 8.3 …
In the quarter ended June 30, 2026, Curis reported a net loss of USD 8.6 million and an operating loss of USD 9.9 million, with cash of USD 5.1 million plus USD 544,000 of restricted cash. The company concluded there is substantial doubt about …
The company's product story has moved in steps. On January 5, 2026, Caring Brands announced an exclusive global license to manufacture and market Emesyl, an over-the-counter nausea relief product, which the company described as expanding a multi-product growth strategy. On February 3, 2026, it …